Regarding the “Efgartigimod versus standard of care in new-onset AChR subtype generalized myasthenia gravis: A prospective cohort study”

IF 3.8 3区医学 Q2 IMMUNOLOGY

Clinical immunology Pub Date : 2025-09-11 DOI:10.1016/j.clim.2025.110603

Hai-Feng Li , Shi-Min Hu , Wei Han , Yan-Su Guo

引用次数: 0

查看原文本刊更多论文

关于“依夫加替莫德与标准护理相比治疗新发AChR亚型广泛性重症肌无力：一项前瞻性队列研究”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical immunology 医学-免疫学

CiteScore

12.30

自引率

1.20%

发文量

212

审稿时长

34 days

期刊介绍： Clinical Immunology publishes original research delving into the molecular and cellular foundations of immunological diseases. Additionally, the journal includes reviews covering timely subjects in basic immunology, along with case reports and letters to the editor.